Retrospective Analysis of Extremity Soft-Tissue Sarcoma

We performed a retrospective analysis of all patients who underwent interdisciplinary surgical therapy for extremity soft-tissue sarcoma at our University Hospital in 2021. A total of 31 patients were included. The inclusion criteria for this analysis were a histologically confirmed diagnosis of extremity STS and treatment at our Center. Patients with abdominal, retroperitoneal, thoracal and trunk soft-tissue sarcoma were excluded. Data including patient characteristics (median age and sex), treatment characteristics (neoadjuvant radiotherapy, neoadjuvant chemotherapy, adjuvant radiotherapy, adjuvant chemotherapy), sarcoma characteristics (tumor location, tumor size, sarcoma subtype), surgical treatment after tumor resection (e.g., primary wound closure, flap), follow up and complications after surgical therapy (in the subgroup of primary wound closure, primary flap reconstruction, secondary flap reconstruction) were extracted by reviewing digital medical records.